Piper Sandler analyst David Amsellem upgraded Organon & Co. (NYSE: OGN) from Underweight to Neutral with a price target of $14.00 (from $5.00).

For an analyst ratings summary and ratings history on Organon & Co. click here. For more ratings news on Organon & Co. click here.

Shares of Organon & Co. closed at $11.26 yesterday.